Mazdutide is a dual GLP-1/glucagon receptor agonist investigated for obesity, lipid metabolism, hepatic steatosis, and cardiometabolic research.
| Purity | >98% |
| Form | Lyophilized powder |
| Storage | -20°C |
Science-backed research overview for this compound
Mazdutide is a synthetic dual agonist peptide that targets both the GLP-1 and glucagon receptors. It is based on the mammalian oxyntomodulin sequence and is engineered for high stability and potency in metabolic research models.
By activating the GLP-1 receptor, Mazdutide promotes satiety and improves insulin secretion. The simultaneous activation of the glucagon receptor increases metabolic rate and enhances energy expenditure. This dual approach is designed to provide comprehensive metabolic regulation.
Research focuses on Mazdutide's potential to significantly reduce body weight and improve markers of metabolic syndrome. It is also highly investigated for its ability to reduce liver fat content (hepatic steatosis) and improve overall lipid profiles in preclinical studies.